首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3845篇
  免费   318篇
  国内免费   6篇
  2024年   5篇
  2023年   30篇
  2022年   71篇
  2021年   117篇
  2020年   75篇
  2019年   80篇
  2018年   99篇
  2017年   85篇
  2016年   149篇
  2015年   221篇
  2014年   247篇
  2013年   286篇
  2012年   312篇
  2011年   319篇
  2010年   234篇
  2009年   180篇
  2008年   227篇
  2007年   199篇
  2006年   202篇
  2005年   192篇
  2004年   165篇
  2003年   160篇
  2002年   145篇
  2001年   31篇
  2000年   17篇
  1999年   26篇
  1998年   31篇
  1997年   26篇
  1996年   27篇
  1995年   22篇
  1994年   20篇
  1993年   16篇
  1992年   13篇
  1991年   13篇
  1990年   13篇
  1989年   10篇
  1988年   6篇
  1987年   11篇
  1986年   3篇
  1985年   10篇
  1984年   13篇
  1983年   10篇
  1982年   7篇
  1981年   6篇
  1980年   3篇
  1978年   7篇
  1977年   4篇
  1976年   3篇
  1975年   7篇
  1970年   3篇
排序方式: 共有4169条查询结果,搜索用时 15 毫秒
891.
892.
893.
Summary A stochastic measure of genetic distance between populations is proposed; unlike currently used measures, it is invariant with respect to union and subdivision of loci. This measure enables a unified quantitative approach to genetic diversity within populations and genetic distance between populations.  相似文献   
894.
We have previously described the development and implementation of a strategy for production of recombinant polyclonal antibodies (rpAb) in single batches employing CHO cells generated by site-specific integration, the SympressTM I technology. The SympressTM I technology is implemented at industrial scale, supporting a phase II clinical development program. Production of recombinant proteins by site-specific integration, which is based on incorporation of a single copy of the gene of interest, makes the SympressTM I technology best suited to support niche indications. To improve titers while maintaining a cost-efficient, highly reproducible single-batch manufacturing mode, we have evaluated a number of different approaches. The most successful results were obtained using random integration in a new producer cell termed ECHO, a CHO DG44 cell derivative engineered for improved productivity at Symphogen. This new expression process is termed the SympressTM II technology. Here we describe proof-of-principle data demonstrating the feasibility of the SympressTM II technology for single-batch rpAb manufacturing using two model systems each composed of six target-specific antibodies. The compositional stability and the batch-to-batch reproducibility of rpAb produced by the ECHO cells were at least as good as observed previously using site-specific integration technology. Furthermore, the new process had a significant titer increase.  相似文献   
895.
Calcium limitation in Daphnia magna   总被引:1,自引:0,他引:1  
The role of ambient calcium concentrations on survival, moulting,growth and egg production was assessed in the cladoceran Daphniamagna. A threshold for survival was found in the range 0.1–0.5mg Ca l–1, even when ionic strength of the medium waskept constant. Accumulated length and length specific dry weightwas retarded at low Ca (0.5–1.0 mg Ca l–1) at foodconcentrations above incipient limiting level. For lower foodlevels, the effect of Ca on growth was less clear. The effectof low Ca on growth rate was most manifest during the firstdays after hatching, reflecting the higher Ca demands of theearly juveniles. Age-specific egg production was strongly reducedat Ca concentrations <10 mg Ca l–1. This was partlyan indirect effect of reduced growth rates, but could also bean effect of higher energetic costs associated with Ca uptakein a Ca-poor medium. The high Ca demands in D.magna may notbe representative of other Daphnia species. Nevertheless, highspecific Ca content seems to be a common property of Daphniaspp. and Ca deficiency could be a major determinant of speciessuccess and community structure among crustacean zooplankton;it also puts constraints on carbon sequestration in the pelagicfood web of softwater lakes.  相似文献   
896.
1. The actions of the calcium channel blocker verapamil were studied at the neuromuscular junction of the frog Rana pipiens. 2. In the presence of 50 microM verapamil, subthreshold endplate potentials were produced, and the quantal content was reduced by a factor of 3. 3. Verapamil (10-50 microM) also reduced the postjunctional membrane sensitivity as measured by (a) carbachol iontophoresis and (b) miniature endplate potential amplitude. In addition, verapamil had a strong inhibitory effect on the postjunctional membrane response to repetitive iontophoretic application of carbachol. 4. Thus, verapamil has both pre- and postsynaptic actions at the neuromuscular junction.  相似文献   
897.
898.
899.
Irregular eating is associated with insulin resistance and metabolic disease in adults but may affect young, growing children differently. We investigated the metabolic effects of unpredictable feeding in female juvenile lambs randomly assigned to receive, for six weeks, maintenance feed given twice daily in equal portions (Control Group, C; n = 24) or the same weekly feed amount in aliquots of variable size at unpredictable times (Unpredictable Group, U; n = 21). Intravenous glucose tolerance tests (IVGTT), insulin tolerance tests (ITT), and measurement of diurnal plasma cortisol concentrations were performed pre and post the dietary intervention. Groups were compared using t test and RM ANOVA. Weight gain was similar in both groups (C 18±2%; U 16±2% of initial body weight). Glucose area under the curve (AUC) was unchanged in C (AUC pre 818±34, post 801±33 mmol.min.l−1), but increased by 20% in U (pre 830±25, post 1010±19 mmol.min.l−1; p<0.0001), with an inadequate insulin response to glucose load (log(AUC insulin first 40 minutes) post intervention C 1.49±0.04 vs U 1.36±0.04 ng.min.ml−1; p = 0.03). Insulin tolerance and diurnal variation of plasma cortisol concentrations were not different between groups. Unpredictable feeding impairs insulin response to glucose in growing lambs despite high quality food and normal weight gain. Irregular eating warrants investigation as a potentially remediable risk factor for disordered glucose metabolism.  相似文献   
900.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号